These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35865390)

  • 1. Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis.
    Rodríguez-Vargas GS; Santos-Moreno P; Rubio-Rubio JA; Bautista-Niño PK; Echeverri D; Gutiérrez-Castañeda LD; Sierra-Matamoros F; Navarrete S; Aparicio A; Saenz L; Rojas-Villarraga A
    Front Cardiovasc Med; 2022; 9():894577. PubMed ID: 35865390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis.
    Botta E; Meroño T; Saucedo C; Martín M; Tetzlaff W; Sorroche P; Boero L; Malah V; Menafra M; Gómez Rosso L; Chapman JM; Kontush A; Soriano E; Brites F
    Atherosclerosis; 2016 Aug; 251():438-444. PubMed ID: 27344073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.
    Mishra R; Singh A; Chandra V; Negi MP; Tripathy BC; Prakash J; Gupta V
    Rheumatol Int; 2012 Aug; 32(8):2377-82. PubMed ID: 21644045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study.
    Šalamon L; Morović-Vergles J; Marasović-Krstulović D; Kehler T; Šakić D; Badovinac O; Vlak T; Novak S; Štiglić-Rogoznica N; Hanih M; Bedeković D; Grazio S; Kadojić M; Milas-Ahić J; Prus V; Stamenković D; Šošo D; Anić B; Babić-Naglić Ð; Gamulin S
    Rheumatol Int; 2015 Dec; 35(12):2047-57. PubMed ID: 26059944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pulse wave velocity and shortened pulse wave propagation time in young patients with rheumatoid arthritis.
    Yildiz M; Soy M; Kurum T; Ozbay G
    Can J Cardiol; 2004 Sep; 20(11):1097-100. PubMed ID: 15457305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.
    Gunning MN; Meun C; van Rijn BB; Daan NMP; Roeters van Lennep JE; Appelman Y; Boersma E; Hofstra L; Fauser CGKM; Rueda-Ochoa OL; Ikram MA; Kavousi M; Lambalk CB; Eijkemans MJC; Laven JSE; Fauser BCJM;
    PLoS One; 2020; 15(3):e0229576. PubMed ID: 32134933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
    Dessein PH; Stanwix AE; Joffe BI
    Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin in rheumatoid arthritis.
    Wisłowska M; Rok M; Jaszczyk B; Stepień K; Cicha M
    Rheumatol Int; 2007 Aug; 27(10):947-54. PubMed ID: 17443329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.
    Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook RD; Kaplan MJ
    J Am Heart Assoc; 2013 Nov; 2(6):e000441. PubMed ID: 24252844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in fat distribution influence the association between BMI and arterial stiffness.
    van den Munckhof ICL; Holewijn S; de Graaf J; Rutten JHW
    J Hypertens; 2017 Jun; 35(6):1219-1225. PubMed ID: 28441693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
    Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
    Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis.
    Lechtenboehmer CA; Jaeger VK; Kyburz D; Walker UA; Hügle T
    Arthritis Rheumatol; 2019 Jan; 71(1):43-49. PubMed ID: 30073800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease?
    Morović-Vergles J; Salamon L; Marasović-Krstulović D; Kehler T; Sakić D; Badovinac O; Vlak T; Novak S; Stiglić-Rogoznica N; Hanih M; Bedeković D; Grazio S; Kadojić M; Milas-Ahić J; Prus V; Stamenković D; Sošo D; Anić B; Babić-Naglić D; Gamulin S
    Rheumatol Int; 2013 May; 33(5):1185-92. PubMed ID: 22965673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.